Federal Data Hub › HRSA 340B · JSON
WACBD - Outreach Services · 340B ID HM981041
ParticipatingHemophilia Treatment Center
Washington Institute for Coagulation is a Hemophilia Treatment Center enrolled in the federal 340B Drug Pricing Program in Seattle, WA. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 8 contract-pharmacy arrangement(s) (1 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.
| Pharmacy | Location | Begin | Terminated | Pharmacy ID |
|---|---|---|---|---|
| ACCREDO HEALTH GROUP INC | CORONA, CA | 2020-12-01 | 2024-07-31 | 81045 |
| ACCREDO HEALTH GROUP INC | WARRENDALE, PA | 2020-12-01 | 2024-07-31 | 23041 |
| ACCREDO HEALTH GROUP INC | MEMPHIS, TN | 2022-07-01 | 2024-07-31 | 45979 |
| ACCREDO HEALTH GROUP INC | KENT, WA | 2020-12-01 | 2024-07-31 | 85081 |
| ACCREDO HEALTH GROUP, INC. | LENEXA, KS | 2020-12-01 | 2024-07-31 | 62883 |
| POSITUDES INC | WESTBURY, NY | 2020-12-01 | 2024-07-31 | 8621 |
| RED CHIP OF NEVADA | IRVINE, CA | 2021-07-01 | — | 95592 |
| Red Chip of Nevada | Irvine, CA | 2021-07-01 | 2026-02-03 | 99860 |
Click a Pharmacy ID to see every other 340B entity using that same pharmacy.
The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.
Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.